Multi-omics integrated circulating cell-free DNA genomic signatures enhanced the diagnostic performance of early-stage lung cancer and postoperative minimal residual disease.
Li Y, Jiang G, Wu W, Yang H, Jin Y, Wu M, Liu W, Yang A, Chervova O, Zhang S, Zheng L, Zhang X, Du F, Kanu N, Wu L, Yang F, Wang J, Chen K.
Li Y, et al. Among authors: wu w, wu m, wu l.
EBioMedicine. 2023 May;91:104553. doi: 10.1016/j.ebiom.2023.104553. Epub 2023 Apr 5.
EBioMedicine. 2023.
PMID: 37027928
Free PMC article.